Comprehensive Assessment of ADMET Risks in Drug Discovery

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|19|2195-2219

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.19, 2009-07, pp. : 2195-2219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Positioning ADMET in silico tools in drug discovery

By Modi S.  

Drug Discovery Today, Vol. 9, Iss. 1, 2004-01 ,pp. : 14-15

Elsevier

Access to resources Recommend Favorite

Comprehensive Profiling of Protein Ubiquitination for Drug Discovery

By  

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3315-3328

Bentham Science Publishers

Access to resources Recommend Favorite

Two-Dimensional (2D) In Silico Models for Absorption, Distribution, Metabolism, Excretion and Toxicity (ADME/T) in Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 1, 2010-01 ,pp. : 116-126

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and ADMET: Where Are We Now

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 4, 2011-02 ,pp. : 467-481

Bentham Science Publishers

Access to resources Recommend Favorite

Comprehensive Essential Gene Identification as a Platform for Novel Antiinfective Drug Discovery

By  

Current Pharmaceutical Design, Vol. 8, Iss. 13, 2002-06 ,pp. : 1155-1172

Bentham Science Publishers

Access to resources Recommend Favorite